Evolving myelodysplastic syndrome in an HIV patient with history of anal cancer and chemotherapy

Mingyue Shi, Xiaobang Hu, Mingyi Chen

Research output: Contribution to journalArticle

Abstract

The incidence of therapy-related myelodysplastic syndromes (t-MDS) has been increasing with the widespread use of highly active antiretroviral therapy (HAART) therapy for HIV and chemotherapy for AIDS-related cancers. The classical dysplastic features in the granulocytes and megakaryocytes may not be easily appreciated. The most reliable distinguishing feature between the hematopoietic dysplasia of t-MDS and that of HIV infection rests on the identification of MDS-related cytogenetic aberrations. Here we report a patient with well-controlled HIV and history of chemotherapy for invasive anal squamous cell carcinoma who developed high-risk t-MDS with complex chromosome abnormalities. Our study emphasizes the importance of diagnosis of MDS in HIV-infected patients, even in the absence of dysplasia, if there are typical cytogenetics changes of MDS. Therefore, the early diagnosis and intervention of t-MDS in HIV-positive patients are critical in the treatment of this aggressiveness disease.

Original languageEnglish (US)
Pages (from-to)213-214
Number of pages2
JournalJournal of Hematopathology
Volume12
Issue number4
DOIs
StatePublished - Dec 1 2019

Fingerprint

Anus Neoplasms
Myelodysplastic Syndromes
HIV
Drug Therapy
Chromosome Aberrations
Therapeutics
Megakaryocytes
Highly Active Antiretroviral Therapy
Granulocytes
Cytogenetics
HIV Infections
Early Diagnosis
Squamous Cell Carcinoma
Acquired Immunodeficiency Syndrome
Incidence
Neoplasms

Keywords

  • Acquired immune deficiency syndrome
  • Cancer
  • Chemotherapy
  • HIV
  • Therapy-related myelodysplastic syndromes (t-MDS)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Hematology

Cite this

Evolving myelodysplastic syndrome in an HIV patient with history of anal cancer and chemotherapy. / Shi, Mingyue; Hu, Xiaobang; Chen, Mingyi.

In: Journal of Hematopathology, Vol. 12, No. 4, 01.12.2019, p. 213-214.

Research output: Contribution to journalArticle

@article{170e63bf6260403bb81991133a8f2f5c,
title = "Evolving myelodysplastic syndrome in an HIV patient with history of anal cancer and chemotherapy",
abstract = "The incidence of therapy-related myelodysplastic syndromes (t-MDS) has been increasing with the widespread use of highly active antiretroviral therapy (HAART) therapy for HIV and chemotherapy for AIDS-related cancers. The classical dysplastic features in the granulocytes and megakaryocytes may not be easily appreciated. The most reliable distinguishing feature between the hematopoietic dysplasia of t-MDS and that of HIV infection rests on the identification of MDS-related cytogenetic aberrations. Here we report a patient with well-controlled HIV and history of chemotherapy for invasive anal squamous cell carcinoma who developed high-risk t-MDS with complex chromosome abnormalities. Our study emphasizes the importance of diagnosis of MDS in HIV-infected patients, even in the absence of dysplasia, if there are typical cytogenetics changes of MDS. Therefore, the early diagnosis and intervention of t-MDS in HIV-positive patients are critical in the treatment of this aggressiveness disease.",
keywords = "Acquired immune deficiency syndrome, Cancer, Chemotherapy, HIV, Therapy-related myelodysplastic syndromes (t-MDS)",
author = "Mingyue Shi and Xiaobang Hu and Mingyi Chen",
year = "2019",
month = "12",
day = "1",
doi = "10.1007/s12308-019-00373-9",
language = "English (US)",
volume = "12",
pages = "213--214",
journal = "Journal of Hematopathology",
issn = "1865-5785",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Evolving myelodysplastic syndrome in an HIV patient with history of anal cancer and chemotherapy

AU - Shi, Mingyue

AU - Hu, Xiaobang

AU - Chen, Mingyi

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The incidence of therapy-related myelodysplastic syndromes (t-MDS) has been increasing with the widespread use of highly active antiretroviral therapy (HAART) therapy for HIV and chemotherapy for AIDS-related cancers. The classical dysplastic features in the granulocytes and megakaryocytes may not be easily appreciated. The most reliable distinguishing feature between the hematopoietic dysplasia of t-MDS and that of HIV infection rests on the identification of MDS-related cytogenetic aberrations. Here we report a patient with well-controlled HIV and history of chemotherapy for invasive anal squamous cell carcinoma who developed high-risk t-MDS with complex chromosome abnormalities. Our study emphasizes the importance of diagnosis of MDS in HIV-infected patients, even in the absence of dysplasia, if there are typical cytogenetics changes of MDS. Therefore, the early diagnosis and intervention of t-MDS in HIV-positive patients are critical in the treatment of this aggressiveness disease.

AB - The incidence of therapy-related myelodysplastic syndromes (t-MDS) has been increasing with the widespread use of highly active antiretroviral therapy (HAART) therapy for HIV and chemotherapy for AIDS-related cancers. The classical dysplastic features in the granulocytes and megakaryocytes may not be easily appreciated. The most reliable distinguishing feature between the hematopoietic dysplasia of t-MDS and that of HIV infection rests on the identification of MDS-related cytogenetic aberrations. Here we report a patient with well-controlled HIV and history of chemotherapy for invasive anal squamous cell carcinoma who developed high-risk t-MDS with complex chromosome abnormalities. Our study emphasizes the importance of diagnosis of MDS in HIV-infected patients, even in the absence of dysplasia, if there are typical cytogenetics changes of MDS. Therefore, the early diagnosis and intervention of t-MDS in HIV-positive patients are critical in the treatment of this aggressiveness disease.

KW - Acquired immune deficiency syndrome

KW - Cancer

KW - Chemotherapy

KW - HIV

KW - Therapy-related myelodysplastic syndromes (t-MDS)

UR - http://www.scopus.com/inward/record.url?scp=85074857897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074857897&partnerID=8YFLogxK

U2 - 10.1007/s12308-019-00373-9

DO - 10.1007/s12308-019-00373-9

M3 - Article

AN - SCOPUS:85074857897

VL - 12

SP - 213

EP - 214

JO - Journal of Hematopathology

JF - Journal of Hematopathology

SN - 1865-5785

IS - 4

ER -